Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis Telesis Bio, a leading provider of DNA and mRNA synthesis ...

SAN DIEGO, March 18, 2025--(BUSINESS WIRE)--Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated ...

Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced that it has entered into ...

SAN DIEGO, March 18, 2025--(BUSINESS WIRE)--Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, ...

Local biotech Telesis Bio recently entered a stock purchase agreement to secure up to $21 million to support its development of synthetic biology tools. The company’s private placement funding ...

WATERTOWN, Mass., April 2, 2025 /PRNewswire/ -- Landmark Bio today announced it has been acquired by Artis BioSolutions ("Artis"), a newly launched company dedicated to streamlining the discovery ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Cabaletta Bio (CABA) to $13 from $26 and keeps a Buy rating on the shares. The firm notes that along with earnings, Cabaletta ...

Korro Bio’s (KRRO) treatment of alpha-1 antitrypsin deficiency received FDA orphan designation, according to a post on the agency’s stie. Published first on TheFly – the ultimate source for ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...